Top Markets
Coin of the day
Eurobio Scientific Société anonyme Eurobio Scientific Société anonyme

Eurobio Scientific Société anonyme

ALERS
Rank in Stocks #10866
Eurobio Scientific Société anonyme designs, develops, and commercializes... Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Share Price
$25.15
Market Cap
$253.18M
Change (1 day)
0.00%
Change (1 year)
-12.08%
Country
FR
Trade Eurobio Scientific Société anonyme (ALERS)

Category

Revenue for Eurobio Scientific Société anonyme (ALERS)
Revenue in Dec 2025 TTM: $197.93M
According to Eurobio Scientific Société anonyme latest financial reports the company's current revenue (TTM) is $197.93M. In 2023 the company made a revenue of $144.42M a decrease compared to the revenue in the year 2022 that was $163.70M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Eurobio Scientific Société anonyme from 2007 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $197.93M 22.76%
2024 $161.23M 11.64%
2023 $144.42M -11.77%
2022 $163.70M -22.07%
2021 $210.04M -8.68%
2020 $230.00M 244.68%
2019 $66.73M 13.70%
2018 $58.69M 14.33%
2017 $51.33M 75.33%
2016 $29.28M -9.46%
2015 $32.34M -13.91%
2014 $37.56M -12.50%
2013 $42.93M 504.10%
2012 $7.11M 9.96%
2011 $6.46M -42.58%
2010 $11.25M 60.45%
2009 $7.01M 19.30%
2008 $5.88M -25.30%
2007 $7.87M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$45.13B 22,702.70%
US
$25.27B 12,666.97%
US
$36.37B 18,275.31%
IE
$20.62B 10,315.16%
US
$6.30B 3,084.67%
US